Mirena 20 mikrog/24 timer Norge - norsk - Statens legemiddelverk

mirena 20 mikrog/24 timer

farmagon - levonorgestrel - intrauterint innlegg - 20 mikrog/24 timer

Gynoflor 0.03 mg / 50 mg Norge - norsk - Statens legemiddelverk

gynoflor 0.03 mg / 50 mg

exeltis healthcare s.l. (1) - Østriol / lactobacillus acidophilus, lyofilt - vaginaltablett - 0.03 mg / 50 mg

Losartan Medical Valley 100 mg Norge - norsk - Statens legemiddelverk

losartan medical valley 100 mg

medical valley invest ab - losartankalium - tablett, filmdrasjert - 100 mg

Losartan Medical Valley 12.5 mg Norge - norsk - Statens legemiddelverk

losartan medical valley 12.5 mg

medical valley invest ab - losartankalium - tablett, filmdrasjert - 12.5 mg

Losartan Medical Valley 50 mg Norge - norsk - Statens legemiddelverk

losartan medical valley 50 mg

medical valley invest ab - losartankalium - tablett, filmdrasjert - 50 mg

Cozaar 100 mg Norge - norsk - Statens legemiddelverk

cozaar 100 mg

n.v. organon - kloosterstraat - losartankalium - tablett, filmdrasjert - 100 mg

Cozaar 50 mg Norge - norsk - Statens legemiddelverk

cozaar 50 mg

n.v. organon - kloosterstraat - losartankalium - tablett, filmdrasjert - 50 mg

Melphalan Macure 50 mg Norge - norsk - Statens legemiddelverk

melphalan macure 50 mg

macure pharma aps - melfalanhydroklorid - pulver og væske til injeksjons-/infusjonsvæske, oppløsning - 50 mg

Onglyza Den europeiske union - norsk - EMA (European Medicines Agency)

onglyza

astrazeneca ab - saxagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Onglyza 5 mg Norge - norsk - Statens legemiddelverk

onglyza 5 mg

orifarm as - saksagliptinhydroklorid - tablett, filmdrasjert - 5 mg